Managers / Q1 2025 · view latest →
Brown Shipley& Co Ltd
CIK 0001912970 · 2 MOORGATE, LONDON, X0, EC2R6AG · 0207 606 9833
Summary
Brown Shipley& Co Ltd reported $177M in U.S.-listed holdings across 63 positions for Q1 2025.
Its largest position, MSFT, represents 13.4% of the portfolio.
Compared with Q4 2024, the fund opened 0 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 97.5% · $172M
- REIT · 2.0% · $4M
- ADR · 0.4% · $720,343
- ETP · 0.1% · $112,997
Quarter-over-Quarter Changes full breakdown →
vs Q4 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| BIIBBIOGEN INC | ADDED | +85 | 107 | +$11,278 | $14,642 |
| PLDPROLOGIS INC. | SOLD OUT | −318 | 0 | −$33,613 | $0 |
| WBDWARNER BROS DISCOVERY INC | SOLD OUT | −943 | 0 | −$9,968 | $0 |
| PYPLPAYPAL HLDGS INC | TRIMMED | −37.0K | 11.1K | −$3M | $726,755 |
| ELLAUDER ESTEE COS INC | TRIMMED | −26.4K | 10.0K | −$2M | $657,954 |
| HONGBPHONEYWELL INTL INC | TRIMMED | −280 | 147 | −$65,328 | $31,127 |
| SNPSSYNOPSYS INC | ADDED | +5.4K | 15.2K | +$2M | $6M |
| COSTCOSTCO WHSL CORP NEW | TRIMMED | −10 | 25 | −$8,424 | $23,645 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $167M | 78 | May 6, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $187M | 70 | Jan 21, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $189M | 72 | Oct 20, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $182M | 74 | Jul 18, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $177M | 63 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $201M | 65 | Feb 18, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $203M | 66 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $222M | 79 | Aug 19, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $318M | 102 | May 16, 2024 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2023 | $181M | 89 | Nov 21, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $244M | 122 | Aug 25, 2023 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2023 | $155M | 121 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.